"J GASTROEN HEPATOL 2019 10.1111/jgh.14750
Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia
Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

HEPATOL INT 2019 10.1007/s12072-019-09975-y
The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015
Jang1, ES; Ki, M; Choi, HY; Kim, KA; Jeong, SH; Jang, ES; Ki, M; Gwak, GY; Kim, KA; Kim, GA; Kim, DY; Kim, DJ; Kim, MW; Kim, SE; Kim, YS; Kim, YS; Kim, IH; Kim, CW; Kim, HD; Kim, HJ; Park, NH; Baik, SK; Suh, JI; Song, BC; Song, IH; Yeon, JE; Lee, BS; Lee, YJ; Jung, YK; Chung, WJ; Cho, SB; Cho, EY; Cho, HC; Cheon, GJ; Chae, HB; Choi, DH; Choi, SK; Choi, HY; Tak, WY; Heo, J; Jeong, SH

J GASTROEN HEPATOL 2019 10.1111/jgh.14856
Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
Sinn1, DH; Kang, D; Chang, Y; Ryu, S; Cho, SJ; Paik, SW; Song, YB; Pastor-Barriuso, R; Guallar, E; Cho, J; Gwak, GY

EUR J ENDOCRINOL 2019 10.1530/EJE-19-0143
Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study
Sinn1, DH; Kang, D; Choi, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY

J HEPATOL 2019 10.1016/j.jhep.2019.02.021
Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial
Lim1, YS; Gwak, GY; Choi, J; Lee, YS; Byun, KS; Kim, YJ; Yoo, BC; Kwon, SY; Lee, HC

BMC CANCER 2019 10.1186/s12885-019-5508-5
Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study
Sinn1, DH; Kang, D; Kang, M; Paik, SW; Guallar, E; Cho, J; Gwak, GY

PLoS One 2019 10.1371/journal.pone.0213547
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW

PLoS One 2019 10.1371/journal.pone.0210730
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW

CANCER IMMUNOL IMMUN 2019 10.1007/s00262-018-2247-4
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
Lee1, JH; Lee, JH; Lim, YS; Yeon, JE; Song, TJ; Yu, SJ; Gwak, GY; Kim, KM; Kim, YJ; Lee, JW; Yoon, JH

ANN SURG 2018 10.1097/SLA.0000000000002318
Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors
Han1, S; Yang, JD; Sinn, DH; Kim, JM; Choi, GS; Jung, G; Ahn, JH; Kim, S; Ko, JS; Gwak, MS; Kwon, CHD; Leise, MD; Gwak, GY; Heimbach, JK; Kim, GS

EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e264
Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study
Kim1, SE; Jang, ES; Ki, M; Gwak, GY; Kim, KA; Kim, GA; Kim, DY; Kim, DJ; Kim, MW; Kim, YS; Kim, YS; Kim, IH; Kim, CW; Kim, HD; Kim, HJ; Park, NH; Baik, SK; Suh, JI; Song, BC; Song, IH; Yeon, JE; Lee, BS; Lee, YJ; Jung, YK; Chung, WJ; Cho, SB; Cho, EY; Cho, HC; Cheon, GJ; Chae, HB; Choi, D; Choi, SK; Choi, HY; Tak, WY; Heo, J; Jeong, SH

LIVER INT 2018 10.1111/liv.13732
Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW

HEPATOLOGY 2018 10.1002/hep.29627
MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis
Caviglia1, JM; Yan, J; Jang, MK; Gwak, GY; Affo, S; Yu, LX; Olinga, P; Friedman, RA; Chen, X; Schwabe, RF

SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895
Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

CAN J GASTROENTEROL HEPATOL 2018 10.1155/2018/7926923
Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography
Lee1, MW; Lim, HK; Rhim, H; Cha, DI; Kang, TW; Song, KD; Min, JH; Gwak, GY; Kim, S; Lu, DSK

J GASTROEN HEPATOL 2018 10.1111/jgh.14042
Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study
Min1, YW; Kim, Y; Gwak, GY; Gu, S; Kang, D; Cho, SJ; Guallar, E; Cho, J; Sinn, DH

DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6
Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS

SCI REP-UK 2018 10.1038/s41598-018-23014-0
Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study
Jang1, HR; Kang, D; Sinn, DH; Gu, S; Cho, SJ; Lee, JE; Huh, W; Paik, SW; Ryu, S; Chang, Y; Shafi, T; Lazo, M; Guallar, E; Cho, J; Gwak, GY

LIVER INT 2018 10.1111/liv.13489
Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
Paik1, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

J HEPATOL 2017
Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study
Sinn1, DH; Kang, D; Jang, HR; Gu, S; Cho, SJ; Paik, SW; Ryu, S; Chang, Y; Lazo, M; Guallar, E; Cho, J; Gwak, GY

DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8
Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation
Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

HEPATOLOGY 2017 10.1002/hep.29187
Monotherapy With Tenofovir Disoproxil Fumarate for Multiple Drug-Resistant Chronic Hepatitis B: 3-Year Trial
Lim1, YS; Lee, YS; Gwak, GY; Byun, KS; Kim, YJ; Choi, J; An, J; Lee, HC; Yoo, BC; Kwon, SY

HEPATOLOGY 2017 10.1002/hep.28916
Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment
Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

J LAPAROENDOSC ADV S 2017 10.1089/lap.2016.0575
Laparoscopic Liver Resection of Hepatocellular Carcinoma with a Tumor Size Larger Than 5 cm: Review of 45 Cases in a Tertiary Institution
Gil1, E; Kwon, CHD; Kim, JM; Choi, GS; Heo, JS; Cho, W; Gwak, MS; Gwak, GY; Joh, JW

ONCOTARGET 2017 10.18632/oncotarget.17072
Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
Yu1, JI; Park, HC; Jung, SH; Choi, C; Shin, SW; Cho, SK; Sinn, DH; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Yoo, BC; Sahinbas, H; Paik, SW

GUT LIVER 2017 10.5009/gnl16403
A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2016.096
Long-term real-world entecavir therapy in treatment-naive hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
Cho1, JY; Sohn, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Koh, KC; Paik, SW; Yoo, BC; Lee, JH

J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647.
Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Gut. 2017 Feb;66(2):323-329. doi: 10.1136/gutjnl-2016-311854. Epub 2016 Sep 6.
Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study
Sinn DH11, Kang D2, Chang Y3,4,5, Ryu S3,4,5, Gu S6, Kim H6, Seong D2, Cho SJ7, Yi BK2,8, Park HD9, Paik SW1, Song YB1,10, Lazo M10, Lima JA10, Guallar E10, Cho J2,3,5,10, Gwak GY1.

Aliment Pharmacol Ther. 2017 Feb;45(4):577-578. doi: 10.1111/apt.13911.
Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia - authors' reply
Ahn JS11, Sinn DH1, Son HJ1,2, Gwak GY1.

Oncotarget. 2017 Jan 10;8(2):2076-2082. doi: 10.18632/oncotarget.10502.
Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma
Joung JG11, Ha SY2, Bae JS1, Nam JY1,3, Gwak GY4, Lee HO1,5, Son DS1,6, Park CK2, Park WY1,3,5.

Aliment Pharmacol Ther. 2017 Jan;45(2):345-353. doi: 10.1111/apt.13866. Epub 2016 Nov 18.
Non-alcoholic fatty liver diseases and risk of colorectal neoplasia
Ahn JS11, Sinn DH1, Min YW1, Hong SN1, Kim HS2, Jung SH2, Gu S3, Rhee PL1, Paik SW1, Son HJ4, Gwak GY1.

Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666.
The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma
Kim JH11, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Gut Liver. 2016 Nov 15;10(6):939-947. doi: 10.5009/gnl15527.
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
Kim JH11, Sinn DH1, Kim K2, Kim H2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

PLoS One. 2016 Nov 15;11(11):e0165722. doi: 10.1371/journal.pone.0165722. eCollection 2016.
Survival Analysis of Single Large (> 5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
Cho Y11,2, Sinn DH3, Yu SJ1, Gwak GY3, Kim JH4, Yoo YJ4, Jun DW5, Kim TY6, Lee HY5, Cho EJ1, Lee JH1, Kim YJ1, Yoon JH1.

Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19.
Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Gut. 2016 Oct;65(10):1721-32. doi: 10.1136/gutjnl-2015-310212. Epub 2016 May 11.
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis
Suk KT11, Mederacke I2, Gwak GY3, Cho SW4, Adeyemi A5, Friedman R6, Schwabe RF7.

Eur Radiol. 2016 Oct;26(10):3437-46. doi: 10.1007/s00330-015-4190-5. Epub 2016 Jan 8.
Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma
Kang TW11, Rhim H2, Lee J1, Song KD1, Lee MW1, Kim YS1, Lim HK1, Jang KM1, Kim SH1, Gwak GY3, Jung SH4.

Liver Int. 2016 Oct;36(10):1490-7. doi: 10.1111/liv.13107. Epub 2016 Mar 24.
The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kim KM11, Sinn DH2, Jung SH3, Gwak GY2, Paik YH2, Choi MS2, Lee JH2, Koh KC2, Paik SW4.

Gut Liver. 2016 Sep 15;10(5):796-802. doi: 10.5009/gnl15368.
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
Lee K11, Sinn DH1, Gwak GY1, Cho HC2, Jung SH3, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Gastroenterology. 2016 Sep;151(3):481-488.e1. doi: 10.1053/j.gastro.2016.06.001. Epub 2016 Jun 7.
Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Sinn DH11, Cho SJ2, Gu S3, Seong D4, Kang D5, Kim H6, Yi BK7, Paik SW1, Guallar E8, Cho J8, Gwak GY9.

Medicine (Baltimore). 2016 Aug;95(35):e4735. doi: 10.1097/MD.0000000000004735.
Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study
Kim JH11, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CH, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026.
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
Sohn W11,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.

PLoS One. 2016 May 5;11(5):e0154986. doi: 10.1371/journal.pone.0154986. eCollection 2016.
Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis
Cho YY11, Lee M1, Kim HC2, Chung JW2, Kim YH3, Gwak GY4, Bae SH5, Kim do Y6, Heo J7, Kim YJ1.

Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25.
Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial
Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.

J Clin Lipidol. 2016 Mar-Apr;10(2):289-98. doi: 10.1016/j.jacl.2015.11.017. Epub 2015 Dec 2.
The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population
Yang MH11, Sung J2, Gwak GY3.

World J Gastroenterol. 2016 Apr 14;22(14):3785-92. doi: 10.3748/wjg.v22.i14.3785.
Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease
Hong YS11, Sinn DH1, Gwak GY1, Cho J1, Kang D1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155.
Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
Ahn JM11, Paik YH1, Min SY1, Cho JY1, Sohn W1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718.
Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods
Kim JM11, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.

Medicine (Baltimore). 2016 Jan;95(1):e2400. doi: 10.1097/MD.0000000000002400.
Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents
Shin JH11, Kwon HJ, Jang HR, Lee JE, Gwak GY, Huh W, Jung SH, Lee JH, Kim YG, Kim DJ, Oh HY.

Medicine (Baltimore). 2016 Jan;95(3):e2578. doi: 10.1097/MD.0000000000002578.
Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
Sinn DH11, Cho SJ, Gwak GY, Cho J, Gu S, Seong D, Kang D, Kim H, Yi BK, Paik SW.

PLoS One. 2015 Dec 22;10(12):e0144777. doi: 10.1371/journal.pone.0144777. eCollection 2015.
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
Ahn JM11,2, Sinn DH1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.

Dig Dis Sci. 2015 Dec;60(12):3794-800. doi: 10.1007/s10620-015-3812-8. Epub 2015 Jul 28.
Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors
Kim HJ11, Sinn DH2, Kim NJ1, Kim JH1, Kim E1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Liver Int. 2015 Nov;35(11):2363-9. doi: 10.1111/liv.12838. Epub 2015 Apr 12.
Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy
Lee JY11, Lim SH1, Lee MY1, Kim H1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Jung CW1, Jang JH1, Kim WS1, Kim SJ1, Kim K1.

J Korean Med Sci. 2015 Nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618. Epub 2015 Oct 16.
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
Lee J11, Sinn DH1, Kim JH1, Gwak GY1, Kim HS2, Jung SH2, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.

Medicine (Baltimore). 2015 Oct;94(43):e1846. doi: 10.1097/MD.0000000000001846.
Factors Associated With Age-related Hearing Impairment A Retrospective Cohort Study
Moon IJ11, Byun H, Woo SY, Gwak GY, Hong SH, Chung WH, Cho YS.

Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3.
Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
Sinn DH11, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.

Radiology. 2015 Jul;276(1):274-85. doi: 10.1148/radiol.15141215. Epub 2015 Feb 25.
Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance
Kang TW11, Lim HK1, Lee MW1, Kim YS1, Rhim H1, Lee WJ1, Gwak GY1, Paik YH1, Lim HY1, Kim MJ1.

Autophagy. 2015;11(7):1187-8. doi: 10.1080/15548627.2015.1054593.
Comment on: HMGB1-dependent and -independent autophagy
Huebener P11, Gwak GY, Schwabe RF.

Gastroenterology. 2015 Jun;148(7):1383-91.e6. doi: 10.1053/j.gastro.2015.02.055. Epub 2015 Mar 4.
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
Lee JH11, Lee JH2, Lim YS3, Yeon JE4, Song TJ5, Yu SJ2, Gwak GY1, Kim KM3, Kim YJ2, Lee JW6, Yoon JH7.

J Viral Hepat. 2015 Jun;22(6):539-50. doi: 10.1111/jvh.12356. Epub 2014 Nov 7.
Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load
Sohn W11, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Radiology. 2015 May;275(2):599-608. doi: 10.1148/radiol.14141568. Epub 2015 Jan 5.
Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study
Song KD11, Lim HK, Rhim H, Lee MW, Kim YS, Lee WJ, Paik YH, Gwak GY, Kim JM, Kwon CH, Joh JW.

J Hepatol. 2015 May;62(5):1112-21. doi: 10.1016/j.jhep.2014.12.009. Epub 2014 Dec 13.
Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors
Sohn W11, Paik YH2, Cho JY1, Lim HY1, Ahn JM1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

PLoS One. 2015 Apr 29;10(4):e0124434. doi: 10.1371/journal.pone.0124434. eCollection 2015.
Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
Sinn DH11, Cho JY1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Transplant Proc. 2015 Apr;47(3):709-17. doi: 10.1016/j.transproceed.2014.10.057.
Renal Outcomes After Liver Transplantation in Fulminant Hepatitis A With Acute Kidney Injury: Comparison With Hepatorenal Syndrome
Park JY11, Gwak GY2, Kim JM3, Oh HJ4, Yi NJ5, Suh KS5, Kim DK1, Lim CS6, Kim YS1, Lee JP7.

Digestion. 2015;91(2):150-7. doi: 10.1159/000369789. Epub 2015 Feb 11.
Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women
Sinn DH11, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.

Hepatogastroenterology. 2015 Mar-Apr;62(138):286-90.
Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses
Huang CS1, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK.

Korean J Intern Med. 2015 Jan;30(1):32-41. doi: 10.3904/kjim.2015.30.1.32. Epub 2014 Dec 30.
Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
Kim HJ11, Cho JY1, Kim YJ1, Gwak GY1, Paik YH1, Choi MS1, Koh KC1, Paik SW1, Yoo BC1, Lee JH1.

Gut. 2014 Dec;63(12):1943-50. doi: 10.1136/gutjnl-2013-306409. Epub 2014 Mar 10.
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Cho JY11, Paik YH1, Sohn W1, Cho HC2, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

PLoS One. 2014 Nov 5;9(11):e112184. doi: 10.1371/journal.pone.0112184. eCollection 2014.
Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
Sinn DH11, Gwak GY1, Cho J2, Paik SW1, Yoo BC1.

Tumori. 2014 Nov-Dec;100(6):645-51. doi: 10.1700/1778.19270.
Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: aspects of gastroduodenal complications
Yu JI1, Cho JY, Park HC, Lim do H, Gwak GY, Paik SW.

Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2.
A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma
Shin JU11, Kim KM2, Shin SW3, Min SY4, Park SU4, Sinn DH4, Gwak GY4, Choi MS4, Lee JH4, Paik SW4, Yoo BC4, Koh KC5.

Hepatogastroenterology. 2014 Sep;61(134):1704-11.
Hepatitis B Virus Reactivation During Anti-Cancer Chemotherapy in Patients with Past Hepatitis B Virus Infection
Kim E1, Yune S, Ha JM, Lee WJ, Hwang JW, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Aliment Pharmacol Ther. 2014 Sep;40(6):695-704. doi: 10.1111/apt.12875. Epub 2014 Jul 30.
Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study
Min YW11, Lim KS, Min BH, Gwak GY, Paik YH, Choi MS, Lee JH, Kim JJ, Koh KC, Paik SW, Yoo BC, Rhee PL.

Gut Liver. 2014 Sep;8(5):543-51. doi: 10.5009/gnl13356. Epub 2014 Jul 25.
Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
Sohn W11, Choi MS1, Cho JY1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

J Korean Med Sci. 2014 Aug;29(8):1113-9. doi: 10.3346/jkms.2014.29.8.1113. Epub 2014 Jul 30.
Relationship of Liver Stiffness and Controlled Attenuation Parameter Measured by Transient Elastography with Diabetes Mellitus in Patients with Chronic Liver Disease
Ahn JM11, Paik YH1, Kim SH1, Lee JH1, Cho JY1, Sohn W1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12.
HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma
Sohn W11, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21.
Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease
Sinn DH11, Gwak GY2, Cho J3, Son HJ4, Paik YH5, Choi MS5, Lee JH5, Koh KC5, Paik SW5, Yoo BC5.

Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12.
The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
Cho JY11, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Liver Int. 2014 May;34(5):695-9. doi: 10.1111/liv.12374. Epub 2013 Nov 24.
Risk factor of community-onset spontaneous bacterial peritonitis caused by fluoroquinolone-resistant Escherichia coli in patients with cirrhosis
Kim J11, Kang CI, Joo EJ, Ha YE, Cho SY, Gwak GY, Chung DR, Peck KR, Song JH.

J Gastroenterol Hepatol. 2014 May;29(5):1043-8. doi: 10.1111/jgh.12504.
Long- term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching
Min YW11, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS.

Scand J Gastroenterol. 2014 Mar;49(3):373-80. doi: 10.3109/00365521.2013.871745. Epub 2013 Dec 19.
Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation
Sohn W11, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Cell Metab. 2014 Mar 4;19(3):539-47. doi: 10.1016/j.cmet.2014.01.014.
High-Mobility Group Box 1 Is Dispensable for Autophagy, Mitochondrial Quality Control, and Organ Function In Vivo
Huebener P11, Gwak GY2, Pradere JP1, Quinzii CM3, Friedman R4, Lin CS5, Trent CM6, Mederacke I1, Zhao E7, Dapito DH8, Lin Y8, Goldberg IJ6, Czaja MJ7, Schwabe RF9.

Gut Liver. 2014 Jan;8(1):58-63. doi: 10.5009/gnl.2014.8.1.58. Epub 2013 Nov 21.
Clinical Features, Image Findings, and Prognosis of Inflammatory Pseudotumor of the Liver: A Multicenter Experience of 45 Cases
Park JY11, Choi MS1, Lim YS2, Park JW2, Kim SU3, Min YW1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.

Transplantation. 2013 Jun 15;95(11):1404-9. doi: 10.1097/TP.0b013e31828d1588.
Steatosis Among Living Liver Donors Without Evidence of Fatty Liver on Ultrasonography: Potential Implications for Preoperative Liver Biopsy
Ahn JS11, Sinn DH, Gwak GY, Kim JM, Kwon CH, Joh JW, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

World J Gastroenterol. 2013;19(14):2256-61. doi: 10.3748/wjg.v19.i14.2256.
Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels
Sinn DH11, Gwak GY, Shin JU, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

A comparison of clevudine and entecavir for treatment-na < ve patients with chronic hepatitis B: results after 2 years of treatment
Hepatogastroenterology. 2013 Mar-Apr;60(122):328-32.
Screening for Extrahepatic Metastases by Additional Staging Modalities is Required for Hepatocellular Carcinoma Patients Beyond Modified UICC Stage T1
Yi J11, Gwak GY, Sinn DH, Kim YJ, Kim HN, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Liver Int. 2012 Jul;32(6):937-44. doi: 10.1111/j.1478-3231.2011.02749.x. Epub 2012 Jan 20.
Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease
Park HN11, Sinn DH, Gwak GY, Kim JE, Rhee SY, Eo SJ, Kim YJ, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

World J Gastroenterol. 2012 Jun 7;18(21):2654-60. doi: 10.3748/wjg.v18.i21.2654.
Clinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma
Min YW11, Gwak GY, Lee MW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Cancer Cell. 2012 Apr 17;21(4):504-16. doi: 10.1016/j.ccr.2012.02.007.
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito DH11, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, Caviglia JM, Khiabanian H, Adeyemi A, Bataller R, Lefkowitch JH, Bower M, Friedman R, Sartor RB, Rabadan R, Schwabe RF.

Am J Gastroenterol. 2012 Apr;107(4):561-7. doi: 10.1038/ajg.2011.400. Epub 2011 Nov 22.
Ultrasonographically Detected Non-Alcoholic Fatty Liver Disease Is an Independent Predictor for Identifying Patients With Insulin Resistance in Non-Obese, Non-Diabetic Middle-Aged Asian Adults
Sinn DH11, Gwak GY, Park HN, Kim JE, Min YW, Kim KM, Kim YJ, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

World J Gastroenterol. 2012 Feb 21;18(7):679-84. doi: 10.3748/wjg.v18.i7.679.
Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway
Gwak GY11, Moon TG, Lee DH, Yoo BC.

Liver Transpl. 2011 Dec;17(12):1467-73. doi: 10.1002/lt.22432.
Predictors of the feasibility of primary endoscopic management of biliary strictures after adult living donor liver transplantation
Lee YY11, Gwak GY, Lee KH, Lee JK, Lee KT, Kwon CH, Joh JW, Lee SK.

Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1643-7. doi: 10.5754/hge08631.
Clinical Significance of Core Gene Mutations During the Course of Genotype C Chronic Hepatitis B Virus Infection
Lee DH11, Gwak GY, Min BH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Hepatogastroenterology. 2011 Jul-Aug;58(109):1291-5. doi: 10.5754/hge07389.
Clinical Impact of the Development of YMDD Mutants in Hepatitis B Virus-Associated Glomerulonephritis
Gwak GY11, Lee CY, Lee DH, Huh W, Koh KC, Kim YG.

Hepatogastroenterology. 2011 Mar-Apr;58(106):522-8.
The Correlation of Hepatitis B Virus Pre-S Mutation with Mitochondrial D-loop Mutations and Common Deletions in Hepatocellular Carcinoma
Gwak GY11, Lee DH, Moon TG, Choi MS, Lee JH, Koh KC, Paik SW, Joh JW, Yoo BC.

Hepatogastroenterology. 2010 Jul-Aug;57(101):801-6.
The Efficacy of Combined Transarterial Chemoembolization and 3-Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma with Main Portal Vein Thrombosis
Park MK11, Gwak GY, Lim do H, Choo SW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

The Clinical Value of F-18-FDG PET/CT for Investigating Unexplained Serum AFP Elevation Following Interventional Therapy for Hepatocellular Carcinoma
Cancer Lett. 2008 Nov 28;271(2):314-22. doi: 10.1016/j.canlet.2008.06.019. Epub 2008 Jul 25.
Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth
Park SC11, Yoon JH, Lee JH, Yu SJ, Myung SJ, Kim W, Gwak GY, Lee SH, Lee SM, Jang JJ, Suh KS, Lee HS.

Hepatogastroenterology. 2008 Nov-Dec;55(88):2028-32.
The Correlation of Hepatitis B Virus Pre-S Mutation with Cellular Oxidative DNA Damage in Hepatocellular Carcinoma
Gwak GY11, Lee DH, Moon TG, Choi MS, Lee JH, Koh KC, Paik SW, Park CK, Joh JW, Yoo BC.

Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1721-4.
Occult Hepatitis B Virus Infection in Chronic Hemodialysis Patients in Korea
Gwak GY11, Huh W, Lee DH, Min BH, Koh KC, Kim JJ, Oh HY.

Transplant Proc. 2007 Dec;39(10):3121-6.
The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy
Gwak GY11, Huh W, Lee DH, Choi MS, Lee JH, Koh KC, Kim SJ, Joh JW, Oh HY.

Clin Exp Rheumatol. 2007 Nov-Dec;25(6):888-9.
Fatal hepatic failure associated with hepatitis B virus reactivation in a hepatitis B surface antigen-negative patient with rheumatoid arthritis receiving low dose methotrexate
Gwak GY11, Koh KC, Kim HY.